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Lung maturation at the terminal sac stage of lung development is characterized by a coordinated increase in terminal sac formation and
vascular development in conjunction with the differentiation of alveolar type I and type II epithelial cells. The Cited2-Tcfap2a/c complex has been
shown to activate transcription of Erbb3 and Pitx2c during mouse development. In this study, we show that E17.5 to E18.5 Cited2-null lungs had
significantly reduced terminal sac space due to an altered differentiation of type I and type II alveolar epithelial cells. In addition, E17 Cited2-null
lungs exhibited a decrease in the number of apoptotic cells, contributing to the loss in airspace. Consistent with the phenotype, genes associated
with alveolar cell differentiation and survival were differentially expressed in Cited2-null fetal lungs compared to those of wild-type littermates.
Moreover, expression of Cebpa, a key regulator of airway epithelial maturation, was significantly decreased in Cited2-null fetal lungs. Cited2 and
Tcfap2c were present on the Cebpa promoter in E18.5 lungs to activate Cebpa transcription. We propose that the Cited2-Tcfap2c complex
controls lung maturation by regulating Cebpa expression. Understanding the function of this complex may provide novel therapeutic strategies for
patients with respiratory distress syndromes.
© 2008 Elsevier Inc. All rights reserved.Keywords: Cited2; Tcfap2c; Cebpa; Lung maturationIntroduction
During early lung development, the foregut endoderm-
derived epithelial cells migrate into the surrounding splanchnic
mesoderm. Through branching morphogenesis, an epithelial
tubular structure forms and differentiates to produce respiratory
bronchioles and terminal alveolar sacs, which integrate with the
endothelial capillary bed (Minoo and King, 1994; Cardoso and
Lu, 2006). At birth, respiratory transition from aqueous to air
breathing requires a mature lung. The prenatal process of lung
maturation is characterized by a coordinated increase in⁎ Corresponding author. Department of Pharmacology, Case Western Reserve
University School of Medicine, Cleveland, OH 44106, USA. Fax: +1 216 368
3395.
E-mail address: yxy36@cwru.edu (Y.-C. Yang).
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doi:10.1016/j.ydbio.2008.02.019terminal sac formation and vascular development in conjunction
with the differentiation of alveolar type I and type II epithelial
cells. Cuboidal alveolar type II epithelial cells undergo marked
ultrastructural and biochemical changes, including depletion of
glycogen, increased synthesis of surfactant proteins and lipids,
increased numbers of lamellar bodies, and secretion of
surfactant proteins into the air space. Surfactant proteins reduce
surface tension at the air-liquid interface and are required for
pulmonary homeostasis (Williams and Mason, 1977; Weaver
and Conkright, 2001; Boggaram, 2003). Alveolar type II cells
terminally differentiate into alveolar type I cells, which are
elongated, flattened cells and are capable of fluid reabsorption.
Cebps are basic leucine zipper transcription factors that are
expressed in several organs and control the expression of genes
important for cell differentiation. In the lung, Cebpa, -b, and -d
are expressed in the type II alveolar epithelial cells and
bronchiolar epithelial Clara cells and regulate gene expression
Table 1
Phenotype of Cited2−/− lungs
Stage No. of Cited2−/− lungs (RPI/PI)
E15.5 3 (2/NA)
E16.5 5 (3/NA)
E17 3 (2/NA)
E17.5 8 (6/8)
E18 4 (2/4)
E18.5 2 (1/2)
RPI: right pulmonary isomerism.
PI: pulmonary immaturity.
NA: not applicable for PI analysis.
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protein), Cyp2b1 (P450 enzyme), and Clara cell secretory
protein (Cassel and Nord, 2003; Basseres et al., 2006; Martis et
al., 2006). Analyses of the embryonic lung show that the
expression of Cebpa, -b, and -c increases during late gestation
(Berg et al., 2006; Breed et al., 1997; Rosenberg et al., 2002),
but no lung phenotype has been reported in the Cebpb−/−,
Cebpd−/−, or Cebpb/Cebpd double knockout mice (Screpanti et
al., 1995; Sterneck et al., 1998; Tanaka et al., 1997). In contrast,
the phenotype of Cebpa conditional knockouts suggests an
important role of Cebpa in the differentiation of respiratory
alveolar epithelium such that immature glycogen-rich pre-type
II cells become mature surfactant-secreting type II cells in the
last few days of gestation (Basseres et al., 2006; Martis et al.,
2006). Loss of Cebpa in the respiratory epithelium in em-
bryos leads to respiratory failure at birth due to an arrest in
type II alveolar cell differentiation, resulting in lack of both
surfactant-secreting type II and differentiated type I alveolar
cells.
Cited2 [CBP/p300-interacting transactivators with glutamic
acid (E) and aspartic acid (D)-rich tail 2] is one of the founding
members of a new family of transcriptional activators.
Expression of Cited2 can be induced by hypoxia, cytokines,
lipopolysaccharide, and shear stress (Bhattacharya et al., 1999;
Sun et al., 1998; Yokota et al., 2003). It functions as a negative
regulator of Hif1 in vitro and in vivo by competing with Hif1a
in binding to the CH1 region of CBP/p300 to inhibit HIF-1-
mediated signaling (Bhattacharya et al., 1999; Freedman et al.,
2003; Xu et al., 2007). Cited2 also acts as a transcriptional
modulator in vitro by interacting with DNA binding proteins,
such as Tcfap2, Smad2/3, Lhx2, PPARα, and PPARγ, to
regulate transcription of their corresponding target genes
(Bamforth et al., 2001; Chou et al., 2006, Glenn and Maurer,
1999; Tien et al., 2004).
Cited2 is widely expressed in both embryonic and extra-
embryonic tissues during early mouse development (Dunwoo-
die et al., 1998; Weninger et al., 2005). It is essential for
embryonic and extra-embryonic tissue development. Mice
lacking Cited2 die at late gestation with numerous develop-
mental defects, including cardiac malformations, adrenal
agenesis, exencephaly, neural crest, left–right patterning, and
placental defects (Bamforth et al., 2001, 2004; Martinez
Barbera et al., 2002; Yin et al., 2002; Weninger et al., 2005;
Withington et al., 2006; Xu et al., 2007). Defects in the
establishment of left–right axis result in abnormal heart looping
and right atrial and right pulmonary isomerism (Bamforth et al.,
2004; Weninger et al., 2005). Some of these abnormalities in
Cited2−/− embryos are hypothesized to be due to reduced
transactivation by Tcfap2 or overexpression of HIF-1-respon-
sive genes (Bamforth et al., 2001, 2004; Yin et al., 2002;
Weninger et al., 2005; Xu et al., 2007).
Here we report that Cited2-null fetal lungs displayed defects
in terminal sac formation due to altered differentiation and a
lower frequency of apoptotic alveolar cells, which likely re-
sulted from significantly decreased expression of Cebpa at late
gestation. Furthermore, Cited2 and Tcfap2c interacted with the
Cebpa gene promoter in the alveolar epithelium to activateCebpa transcription. These results strongly suggest that Cited2
plays a novel role in pulmonary maturation through its coac-
tivation function with Tcfap2c to regulate Cebpa expression.
Materials and methods
Mouse strains and generation
Cited2 heterozygous mice were genotyped by Southern blot analysis (Yin et
al., 2002) and backcrossed at least 13 generations into the C57BL/6J genetic
background. Twenty-five Cited2-null lungs between E15.5 and E18.5 from the
intercrosses of Cited2 heterozygotes on the C57BL/6J genetic background
(Table 1) and 28 wild-type lungs from their littermates were dissected. One half
of each embryonic lung (right or left lobe) was fixed in 4% paraformaldehyde
for histology, immunohistochemistry, in situ hybridization, and/or the terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL)
assay, and the other half was frozen for RNA isolation.
Morphological analysis
Hematoxylin and eosin (HE)-stained sections were used for histological
examination. Immunohistochemistry was carried out by using rabbit polyclonal
anti-prosurfactant protein B (Chemicon International, Temecula, CA), mouse
monoclonal anti-vimentin (40E-C, Developmental Studies Hybridoma Bank,
Iowa City, IA), mouse monoclonal anti-cytokeratin (TROMA-I, Developmental
Studies Hybridoma Bank), rabbit monoclonal anti-Cebpa (C-18, Santa Cruz
Biotechnology, Santa Cruz, CA), rabbit polyclonal anti-Tcfap2c (Santa Cruz
Biotechnology), mouse monoclonal anti-Titf1 (8G7G3/1, DakoCytomation,
Carpinteria, CA), mouse monoclonal anti-Ki-67 (B56, BD PharMingen, San
Diego, CA), and rat monoclonal anti-CD31 (MEC13.3, BD PharMingen)
antibodies on cryosections. The reactions were detected by the Labeled
Streptavidin Biotin Kit (DakoCytomation). Electron microscopy was performed
on lung tissues obtained from E18.5 Cited2-null embryos and littermate controls
after fixation in 2.5% glutaraldehyde and 2% paraformaldehyde solution,
postfixation in 1.5% potassium ferrocyanide and 1% osmium tetroxide solution,
dehydration in ascending alcohols, cleared with propylene oxide, and infiltration
with a mixture of Epon resin and propylene oxide. Seventy-nanometer sections
stained for contrast with uranyl acetate and lead citrate were viewed and
photographed on a JEOL 1200CX electron microscope.
X-gal staining and TUNEL assay
X-gal staining was performed on lung cryosections using standard
procedures (Martinez Barbera et al., 2002). TUNEL assay was performed on
3 sections from all of the collected E16.5, E17, and E17.5 Citedd2-null lungs
(see Table 1 for actual sample numbers) and three of the matching E16.5, E17,
and E17.5 wild-type lungs using ApopTag Peroxidase In Situ Apoptosis
Detection Kit (Chemicon International) according to the manufacturer's
instructions. The percentages of TUNEL-positive cells were then calculated
from 5 random selected fields of each section. On average, approximately 500
alveolar cells were counted in each field.
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Total RNAwas isolated from the lung tissue using Trizol reagent following
the manufacturer's protocol (Invitrogen, Carlsbad, CA). Ten-microgram total
RNA was loaded per lane for formaldehyde agarose gel electrophoresis and
transferred to a nylon membrane. Equal loading was demonstrated by 18S RNA
levels. Five-microgram total RNA was used for cDNA synthesis using the
SuperScript™ First Strand Synthesis System (Invitrogen). Real-time PCR
reactions were carried out with diluted RT reaction products using iQ™ SYBR
Green Supermix PCR kit and iCycler machine (Bio-Rad). Transcript of β-actin
and HPRT was used as an internal control for normalization.
Plasmids, DNA transfection, luciferase reporter assay, and siRNA
A segment of the Cebpa gene from nucleotides −805 to +117 containing the
entire 5′-UTR was amplified from mouse genomic DNA and subcloned into
pGL3 (C/EBPα-805-luc). Mouse Cited2 cDNAwas subcloned into pcDNA3.1
(−)B and the deletion of C-terminal residues (ΔCR2) was introduced into this
Cited2 expression vector (Chou et al., 2006). Tcfap2c cDNA subcloned into
pcDNA3.1 was kindly provided by Dr. Frederick E. Domann (Li et al., 2006).
CMV-CBP and CMV-CBPΔCH1 were gifts from Dr. Paul K. Brindle (Kasper et
al., 2005). HeLa cells were transfected using FuGENEHD Transfection Reagent
(Roche Diagnostics) following the manufacturer's instructions. Luciferase
activity in cell lysates was detected by Dual-luciferase Reporter Assay System
(Promega, Madison, WI) and normalized according to renilla luciferase activity
of cotransfected pRL-CMV. For siRNA knockdown experiment, HeLa cells
were transfected with Cited2 siRNA or siRNA control (Chou et al., 2006) using
Effectene transfection reagent (Qiagen, Hilden, Germany) for 24 h following the
manufacturer's instruction.
Chromatin immunoprecipitation (ChIP) assay
Lung tissues from 4 each of E18.5 wild-type and Cited2−/− embryos were
combined for the ChIP assay using the ChIP Assay Kit (Upstate Cell Signaling
Solutions, Lake Placid, NY) according to the manufacturer's protocol.
Chromatin was immunoprecipitated with 1 μg rabbit anti-Cited2, -Tcfap2c,
-Cebpa (Santa Cruz Biotechnology), or -acetylated-Histone H3 (Upstate Cell
Signaling Solutions) antibody. Immunoprecipitated samples were analyzed by
PCR with primers specific for the overlapping Sp1/Sp3 and Tcfap2a/c binding
sites in the Cebpa promoter (for amplification of −805 to −661 region: sense,
5′-tggagacgcaatgaaaaaga-3′, antisense, 5′-gaactacagggtcccacgg-3′; for −332 to
−159: sense, 5′-ctggaagtgggtgacttagagg-3′, antisense, 5′-gggagcatagtgctagtg-Fig. 1. Cited2 expression in developing lungs. (a) Ten-microgram total RNA isolated
probe for Cited2. The 18S RNA levels were used as the loading control. (b) Cited2 exp
from the Cited2-lacZ allele in E17.5 heterozygotes (A, D), followed by immunostainin
present in both cytokeratin-positive cells (arrows in panels B and C) and vimentin-po
portions of panels B and E (shown as rectangles) for visualization purpose. Only a few
(B). The X-gal-positive signals (blue in panels A, D) were pseudo-colorized to bluegaga-3′; for −54 to +123: sense, 5′-gatgcccgaccctctataaaa-3′, antisense,
5′-actccatgggggagttagagtt-3′).
Statistical analysis
Statistical difference between two independent groups was assessed by
Independent-samples t test; p≤0.05 was considered statistically significant.Results
Expression of Cited2 in mouse embryonic and fetal lungs
Northern analysis showed that Cited2 was expressed in the
E13.5–18.5 lung tissues examined, with higher expression in
the E17.5 and E18.5 lungs (Fig. 1a), suggesting its potential
involvement in lung maturation. To further explore the
developmental expression pattern of Cited2 in mouse embryo-
nic lung, Cited2 expression was assayed on lung cryosections
by detecting β-galactosidase activity from the Cited2-lacZ
allele in E17.5 heterozygotes, followed by immunostaining
with the epithelial marker, cytokeratin, or the mesenchymal
marker, vimentin. As shown in Fig. 1b, X-gal-positive cells
were present in both peripheral epithelial cells that were
immunopositive for cytokeratin (Fig. 1b: B and C) and
mesenchymal cells that were immunopositive for vimentin
(Fig. 1b: E and F). Only a few X-gal-positive cells were seen in
the proximal airways (Fig. 1b: B).
Right pulmonary isomerism and pulmonary immaturity in
Cited2-null lungs
Previous studies showed that approximately two thirds of
Cited2-null embryos had right pulmonary isomerism: 4 lung
lobes on both sides, as opposed to the normal arrangement with
1 lung lobe on the left and 4 lung lobes on the right (Bamforth et
al., 2004; Weninger et al., 2005). This overall gross phenotypefrom E13.5–18.5 lung tissue was subjected to Northern analysis with a specific
ression was examined on lung cryosections by detecting β-galactosidase activity
g of cytokeratin (B, C) or vimentin (E, F), showing that X-gal-positive cells were
sitive cells (arrows in panels E and F). Panels C and F are digitally enlarged from
X-gal-positive cells (arrow heads in panel B) were seen in the proximal airways
(B, C) and green (E, F) for the ease in visualization. Br: bronchus.
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Table 1, 16 out of 25 (64%) Cited2-null embryos between E15.5
and E18.5 had right pulmonary isomerism. Furthermore, the
lobe sizes of Cited2-null lungs were much smaller in appearance
than those of wild-type lungs (Supplemental Fig. 1).
All the lung tissues in Table 1 were examined by HE-stained
sections. Essentially, no apparent phenotypic differences could
be detected between wild-type (Fig. 2a: A) and Cited2-null (Fig.
2a: B) lungs at E16.5. At E17.5 and E18.5, the dilated terminal
sacs of wild-type distal lungs were lined with squamous type I
epithelial cells and cuboidal type II cells. The mesenchyme and
epithelium were thin with pulmonary capillaries extensively
invaded in close proximity to type I epithelial cells (Fig. 2a: C,
E), indicating structural maturation at these stages. In contrast,
all 14 Cited2-null distal lungs at E17.5 to E18.5 exhibited
remarkably abnormal histopathology, characterized by reduced
terminal sac space with completely obliterated alveolar structure
and the terminal sacs were surrounded by cuboidal epithelial
cells and lacked squamous type I cells (Fig. 2a: D, F), consistent
with pulmonary immaturity. Moreover, all 14 E17.5 to E18.5
Cited2-null embryos had pulmonary immaturity, but only 9 out
of 14 (64%) had right pulmonary isomerism, suggesting that
these two are independent phenotypes.Fig. 2. Pulmonary immaturity in Cited2−/− embryonic lungs. (a) HE-stained sections
(C, D), and E18.5 (E, F). Representative sections revealed no apparent phenotypic dif
E18.5 (E) wild-type lungs had dilated terminal sacs lined by both squamous type
mesenchyme and epithelium. In contrast, E17.5 (D) and E18.5 (F) Cited2−/− lungs ha
squamous type I cells. (b) Electron microscopy was performed on lungs from E18.
contained highly organized rosette glycogen (GLY), apical microvilli (MV), and num
observed in the lumen of the peripheral airspace (A). In contrast, cytoplasmic glyco
observed in type II epithelial cells of Cited2−/− embryos. The number of squamous ty
of Cited2−/− embryos (B).Compared with wild-type littermates (Fig. 2b: A), E18.5
Cited2-null lungs (Fig. 2b: B) appeared immature at the
ultrastructural level. In controls, cuboidal type II cells contained
highly organized rosette glycogen, apical microvilli, and
numerous lamellar bodies, which are the intracellular storage
forms of surfactant proteins. Lamellar bodies and secreted
surfactant proteins were observed in the lumen of peripheral
airspaces. In contrast, cytoplasmic glycogen was dispersed,
apical microvilli were smaller, and lamellar bodies were
markedly decreased in type II epithelial cells of Cited2-null
embryos. Squamous type I cells were lacked and secreted
surfactant proteins were markedly decreased in the airspace of
Cited2-null embryos.
Altered differentiation of alveolar epithelial cells in Cited2-null
fetal lungs
Cellular differentiation is accompanied by the expression of
markers that reflects the degree of maturation of the lung
epithelium. As the histological analysis indicated that distal
epithelial differentiation in Cited2-null fetal lungs was
impaired, we examined the expression of lung epithelial
markers in wild-type and Cited2-null lungs at E17.5 and E18.from wild-type (A, C, E) and Cited2−/− (B, D, F) lungs at E16.5 (A, B), E17.5
ferences between wild-type (A) and Cited2−/− (B) lungs at E16.5. E17.5 (C) and
I epithelial cells (arrow) and cuboidal type II epithelial cells and a thinned
d reduced terminal sacs that were surrounded by cuboidal type II cells and lacked
5 Cited2−/− embryos and littermate controls. In controls, cuboidal type II cells
erous lamellar bodies (*). Lamellar bodies and secreted surfactant proteins were
gen was dispersed, apical microvilli were smaller, and lamellar bodies were not
pe I cells and secreted surfactant proteins was markedly decreased in the airspace
Fig. 3. Decreased expression of alveolar and Clara epithelial marker genes in Cited2−/− embryonic lungs. (a) Real-time RT-PCRwas performed to analyze relative T1α,
Aqp5, SP-A, SP-B, SP-C, SP-D, and CC10 mRNA levels in E18 Cited2−/− lungs, compared with those in wild-type littermates. *pb0.01. (b) Immunohistochemistry
for proSP-B confirmed that E18 Cited2−/− lungs (B) had decreased proSP-B expression compared to wild-type littermates (A).
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in type II epithelial cells increases prior to birth (Boggaram,
2003), while SP-B and SP-C play critical roles in enhancing the
spreading and adsorption of phospholipids to an air–liquid
interface and promoting the reduction of surface tension
(Boggaram, 2003; Weaver and Conkright, 2001). The mRNA
levels of SP-A, SP-B, SP-C, and SP-D examined by real-time
RT-PCR were significantly down-regulated in the Cited2-null
lungs at E17.5 (data not shown) and E18 (Fig. 3a). In addition,
Cited2-null fetal lungs showed decreased expression of proSP-
B by immunostaining in the peripheral epithelial cells (Fig. 3b).
These results suggest that expression of surfactant proteins is
decreased in alveolar epithelial cells of Cited2-null fetal lungs.
Consistent with the observation that the terminal sacs lacked
squamous type I cells in the absence of Cited2 (Figs. 2a: F, b:
B), the mRNA levels of alveolar type I cell markers, such as T1-
α and aquaporin 5, were significantly decreased in Cited2-null
fetal lungs (Fig. 3a). These findings support the altered
differentiation of alveolar epithelial cells in Cited2-null fetal
lungs. In contrast to the immaturity of Cited2-null distal lungs,
no obvious histological abnormalities in conducting airways
were observed. However, the mRNA level of CC10 (Clara cell
10 kDa protein), a marker for Clara epithelial cells, was
decreased in Cited2-null fetal lungs (Fig. 3a).Fig. 4. Decreased number of apoptotic alveolar cells and increased expression of G
showed that fewer TUNEL-positive cells were present in E17 Cited2−/− lungs (B) com
expression of Gli1 in E17 Cited2−/− lungs compared to wild-type littermate lungs. EProliferation and apoptosis of alveolar cells in Cited2-null
fetal lungs
Pulmonary immaturity is dependent on the balance between
the rates of cell proliferation, differentiation and programmed
cell death (apoptosis). To test whether the cellular accumulation
in Cited2-null fetal lungs, which may explain the loss of the
airspace (Fig. 2a: D, F), is due to increased cell proliferation,
immunostaining of Ki-67, a nuclear antigen present in
proliferating cells, was performed on lung sections between
E16.5 and E18.5. No obvious difference in the proportion of Ki-
67-positive cells was observed in E16.5 to E18.5 Cited2-null
lungs compared with that of wild-type lungs (data not shown),
suggesting that the cellular accumulation in Cited2-null fetal
lungs could not be explained by an increase in cell proliferation
alone.
We further investigated alveolar cell apoptosis by the
TUNEL assay. Compared with wild-type lungs (Fig. 4a: A),
apoptotic alveolar cells in Cited2-null lungs (Fig. 4a: B) at E17
were significantly decreased (pb0.001), which only had few
apoptotic cells. Moreover, the mRNA level of Gli1, which has
been shown to be a positive regulator of Bcl2 (Bigelow et al.,
2004), was 2-fold higher in E17 Cited2-null lungs than that in
wild-type littermates (Fig. 4b). These data suggest that alveolarli1 in Cited2−/− embryonic lungs. (a) Representative pictures of TUNEL assay
pared to wild-type littermate lungs (A). (b) Real-time RT-PCR showed increased
xpression levels are presented as a percentage of β-actin expression. *pb0.01.
Fig. 5. Expression of genes relevant to lung development in Cited2−/− embryonic lungs. (a) Real-time RT-PCR was used to analyze relative Titf1, Foxa1, Foxa2,
Cebpa, TGFβ2, VEGF, and VEGFR2 mRNA levels in E18 Cited2−/− lungs, compared with those in wild-type littermates. *pb0.01. (b) Immunohistochemistry for
Titf1 showed that alveolar epithelial cells of both wild-type (A) and Cited2−/− (B) peripheral lungs homogeneously expressed Titf1. (c) Compared to the wild-type
littermate (A), the proportion of Cebpa-positive cells detected by immunostaining was markedly decreased in E18.5 Cited2−/− lungs where the terminal sac structure
was completely obliterated (B).
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normal terminal sac formation during lung development.
Expression of transcription factors for alveolar epithelial cell
differentiation in Cited2-null fetal lungs
We then examined the expression of transcription factors
involved in lung branching morphogenesis and alveolar cell
differentiation. Cebpa regulates the expression of genes that
mediate cell differentiation and proliferation, lipid biosynthesis
and metabolism, and host defense (Cassel and Nord, 2003).
Titf1, Foxa1, and Foxa2 are expressed in respiratory epithelial
cells lining both the conducting and peripheral airways and play
distinct roles in lung formation and function. Titf1 and Foxa2 are
required for Cebpa gene expression and Cebpa also regulates
Foxa2 gene expression (Martis et al., 2006). In this study,
there was no obvious difference in Titf1, Foxa1, and Foxa2
mRNA levels between wild-type and Cited2-null lungs at E17.5
(data not shown) and E18 (Fig. 5a). By immunostaining, Titf1
was expressed in the alveolar epithelial cells of wild-type
peripheral lungs at E17.5 (data not shown) and E18.5 (Fig. 5b:Fig. 6. Regulation of the Cebpa promoter by Tcfap2c and Cited2. (a) Overlappin
overlapping Sp1/Sp3 and Tcfap2c binding site. A1 and A2 represent overlapping Sp1
immunoprecipitation (P1 to P6) are indicated. (b) Comparison of the Tcfap2c binding
rat, and human. (c) ChIP assays using E18.5 wild-type lungs with antibodies to C
chromatin was used as the PCR template. 1, 2, 3, and 4 are separate samples. (d) Re-
then re-immunoprecipitating with second antibodies to Tcfap2c or Cited2. (e) Co-t
Cited2, Cited2ΔCR2, Tcfap2c, CBP, and/or CBPΔCH1 in different combinations, fo
HeLa cells with si-Cited2 or si-Control for 24 h, followed by cotransfection with C/EB
(g) Transfection of HeLa cells with si-Cited2 or si-Control for 24 h, followed by reA), as previously reported (Stahlman et al., 1996). In Cited2-null
lungs at E17.5 (data not shown) and E18.5 (Fig. 5b: B), the
cuboidal epithelial cells of the terminal sacs expressed Titf1
protein in a relatively homogenous pattern. Interestingly, the
mRNA level of Cebpa was significantly decreased in Cited2-
null lungs at E17.5 (data not shown) and E18 (Fig. 5a), compared
with that in the wild-type lungs. While 31% of the total number
of respiratory cells in wild-type lungs at E17.5 (data not shown)
and E18.5 (Fig. 5c: A) were immunopositive for Cebpa, only
15% were Cebpa-immunopositive cells in Cited2-null lungs at
E17.5 (data not shown) and E18.5 (Fig. 5c: B). Thus, we propose
that decreased expression of Cebpa could be responsible for
pulmonary immaturity in Cited2-null fetal lungs.
Cited2 and Tcfap2c interact with the Cebpa promoter
Sp1 and Sp3 are major transcription factors controlling the
expression of Cebpa, a pleiotropic transcriptional activator
responsible for the expression of various genes during
adipogenesis. Sp1/Sp3-mediated transcription of Cebpa is
repressed by a weaker transcriptional activator, Tcfap2a, ing Sp1/Sp3 and Tcfap2a/c binding sites in the Cebpa promoter. C represents
/Sp3 and Tcfap2a binding sites. The positions of PCR primers used for chromatin
sequence in the Esr1 promoter with those in the Cebpa promoters from mouse,
ited2, Tcfap2c, acetylated histone H3, and mouse IgG. Input lane: 1% of total
ChIP assays by immunoprecipitating with first antibodies to Cited2 or Tcfap2c,
ransfection of HeLa cells with C/EBPα-805-luc or C/EBPα-711(G/C)-luc plus
llowed by luciferase assays 24 h after transfection. *pb0.01. (f) Transfection of
Pα-805-luc and Tfap2c in different combinations for 24 h and luciferase assays.
al-time RT-PCR with specific primers for human Cited2 and GAPDH.
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binding to overlapping Sp1/Sp3 and Tcfap2a binding sites at
nucleotides −252 to −234 (A1 site, Fig. 6a) and +83 to +96 (A2
site, Fig. 6a) of the Cebpa gene (Jiang and Lane, 2000). Tcfap2
represents a family of three closely related and evolutionarily
conserved transcription factors, Tcfap2a, -b, and -c, which have
regulatory functions in control of apoptosis, cell cycle, and gene
expression (Hilger-Eversheim et al., 2000). A previous study
showed that Tcfap2c activates Esr1 gene transcription through
its high-affinity binding to the imperfect palindrome sequence,
CCCTGCGGGG, in the Esr1 promoter (McPherson et al.,
1997). Overlapping Sp1/Sp3 and Tcfap2c binding sites are
present in the conserved regions among mouse (C site, Fig. 6a),
rat, and human Cebpa genes (Fig. 6b), suggesting that they may
function as potential DNA binding sites important for Cebpa
expression.
Since the Cited2-Tcfap2a/c complex activates transcription
of Erbb3 and Pitx2c during mouse development (Bamforth et
al., 2004; Weninger et al., 2005), we tested whether endogenous
Cited2 and Tcfap2 physically interact with overlapping Sp1/Sp3
and Tcfap2a/c binding sites of the Cebpa promoter by the ChIP
assay. Using E18.5 wild-type lungs, specific ChIP signals with
antibodies to Cited2 were reproducibly detected with primers
spanning the C site (Fig. 6c), but not with primers spanning A1
and A2 sites or using Cited2-null lungs (data not shown). In
addition, specific and reproducible ChIP signals with antibodies
to Tcfap2c and acetylated histone H3 were detected using
primers spanning the C site (Fig. 6c). To further examine
whether endogenous Cited2 and Tcfap2 simultaneously interact
with the C site, re-ChIP assays were performed by immuno-
precipitating with first antibodies to Cited2 or Tcfap2c, then re-
immunoprecipitating with second antibodies to Tcfap2c or
Cited2. As shown in Fig. 6d, specific re-ChIP signals were
reproducibly detected with primers spanning the C site.
Previous studies have shown that by RT-PCR, Tcfap2c
(Oulad-Abdelghani et al., 1996), but not Tcfap2a and Tcfap2b
(Moser et al., 1995), was specifically expressed in adult mouse
lung, ovary, and testis. These data therefore suggest that Cited2
and Tcfap2c may specifically interact with the C site of the
Cebpa promoter in the respiratory epithelium.
Cited2, Tcfap2c, and CBP activate the Cebpa promoter
To determine whether Cited2 and Tcfap2c could activate the
Cebpa promoter, the Cebpa promoter/reporter plasmid (C/
EBPα-805-luc) was transiently transfected into HeLa cells that
express high levels of Sp1 and Sp3 but low levels of Tcfap2 and
Cebpa. As shown in Fig. 6e, C/EBPα-805-luc activity was
highly activated when the promoter/reporter alone was
transfected. This strong promoter activity, most likely activated
by endogenous Sp1 or Sp3, was not affected by the
cotransfection of Cited2 or CBP alone, but was inhibited by
Tcfap2c (by a factor of 0.24). This inhibition was totally
abolished when the Tcfap2c binding site was mutated from C to
G at nucleotide −711, suggesting that Tcfap2c competitively
binds to the C site with higher affinity. The weak C/EBPα-805-
luc activity in the presence of Tcfap2c was further decreased (bya factor of 0.57, Fig. 6f) by 67% knockdown of endogenous
expression of Cited2 using siRNA specific for Cited2 (Fig. 6g)
and activated by Cited2 (by a factor of 2.92) and Cited2 plus
CBP (by a factor of 3.14) but not by Cited2ΔCR2 or
CBPΔCH1 (Fig. 6e), which is consistent with previous findings
that the C-terminus of Cited2 interacts with the first helix of the
Tcfap2c dimerization motif and the CH1 region of CBP to
activate Tcfap2-mediated transcription (Braganca et al., 2003).
These data suggest that Tcfap2c, Cited2, and CBP can
synergistically activate the Cebpa promoter.
Discussion
In this study, we describe pulmonary immaturity in Cited2-
null embryos displaying defects in terminal sac formation due to
an accumulation of undifferentiated and less apoptotic alveolar
cells. Consistent with the phenotype, Cited2-null fetal lungs
differed in the expression of genes associated with alveolar cell
differentiation and survival. The expression of Cebpa, a key
regulator in airway epithelial maturation, was significantly
decreased in Cited2-null fetal lungs. Endogenous Cited2 and
Tcfap2c physically interacted with the Cebpa gene promoter in
the respiratory epithelium at E18.5 and activated Cebpa
transcription. These results indicate that we have identified a
novel role for Cited2 in pulmonary maturation that explains the
pulmonary immaturity in mice lacking Cited2.
Mice lacking Cited2 die at late gestation with numerous
developmental defects. Our previous study showed that
pulmonary immaturity is independent of cardiac malformations
because HIF-1α heterozygosity rescued outflow tract and
interventricular septum defects, but did not rescue pulmonary
immaturity in Cited2-null embryos (Xu et al., 2007). The
present study suggests that pulmonary immaturity is also
independent of left–right patterning defects. Only one third of
Cited2 knockouts had neural tube defects (Xu et al., 2007), but
all Cited2 knockouts had pulmonary immaturity, suggesting
that pulmonary immaturity is also independent of neural tube
defects. Thus, pulmonary immaturity in Cited2 knockouts is
likely a primary defect. Lung epithelium-specific knockout of
Cited2 is required to address this issue ultimately.
Previous studies have shown that Cebpa expressed in type II
pneumocytes regulates the expression of (a) SP-B, Abca3,
Scd1, Fas, and Fabp5 that mediate lipid synthesis; (b) SP-B and
SP-C that reduce alveolar surface tension; (c) SP-A, SP-D, Lys,
and Hc that contribute to the anti-inflammatory activities; (d)
Aqp5 and TGF-β2 that mediate alveolar epithelial cell
differentiation; and (e) Gli1 with anti-apoptotic function (Cassel
and Nord, 2003; Basseres et al., 2006; Martis et al., 2006). Loss
of Cebpa in the respiratory epithelium in embryos leads to
respiratory failure at birth due to pulmonary immaturity with an
arrest in the type II alveolar cell differentiation and reduced
peripheral saccules (Basseres et al., 2006; Martis et al., 2006). In
this study, histopathological abnormalities consistent with
pulmonary immaturity observed in Cited2-null fetal lungs,
including reduced alveolar spaces, lack of squamous type I cells
in the terminal sacs, and immature type II cells with dispersed
cytoplasmic glycogen, smaller apical microvilli, and markedly
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features observed in the lung-specific and conditional Cebpa
knockouts (Basseres et al., 2006; Martis et al., 2006). Moreover,
significantly decreased expression of Cebpa (Fig. 5) and
differentially expressed Cebpa target genes in Cebpa-null
lungs including SP-A, -B, -C, -D, Aqp5, TGF-β2, and Gli1
(Figs. 3, 4b, 5a) were demonstrated in Cited2-null fetal lungs.
These results strongly suggest that Cited2 functions genetically
upstream of Cebpa and the down-regulated expression of Cebpa
is most likely responsible for the pulmonary immaturity in
Cited2-null fetal lung.
In addition to Cebpa knockouts, lung-specific Cebpa
transgenic animals are embryonic lethal with defects in lung
branching morphogenesis (Berg et al., 2006). These animal
studies indicate that an appropriate level of Cebpa is critical for
normal lung development. During adipocyte differentiation,
Cebpa transcription is repressed by Tcfap2a through its
competitive binding to the A1 and A2 sites with Sp1/Sp3
(Jiang and Lane, 2000). In the present study, the transfection
assay showed that strong C/EBPα-805-luc activity, most likely
activated by endogenous Sp1/Sp3, was inhibited by Tcfap2c
through its competitive binding to the C site on the Cebpa
promoter (Fig. 6e). This C site is highly conserved among
mouse, rat, and human Cebpa gene (Fig. 6b). In addition, the
weak C/EBPα-805-luc activity, through the binding of Tcfap2c,
was further activated by Cited2 and CBP (Fig. 6e), suggesting
that Cited2 and CBP, transcriptional coactivators for Tcfap2c,
may regulate Cebpa transcription to maintain its appropriate
level in cells. Several lines of evidence support this idea: (a)
endogenous Cited2 and Tcfap2c both occupied the C site of the
Cebpa promoter in fetal lungs (Figs. 6c, d); (b) acetylated
histone H3 can be detected in this region, indicating that it is a
transcriptionally active site (Fig. 6c); (c) mutant mice bearing
deletions in the CH1 domain of CBP have similar pulmonary
defects, including thickened interstitial septa and decreased
alveolar airspace, as those observed in Cited2 and Cebpa
knockouts (Kasper et al., 2005).
It is also known that Cited2-null embryos develop adrenal
agenesis (Bamforth et al., 2001; Val et al., 2007), likely
resulting in fetal glucocorticoid insufficiency. Previous study
has shown that corticotropin-releasing hormone-deficient mice,
which as a consequence are also glucocorticoid insufficient,
exhibit morphologic alterations in the lungs at E17.5 including
defects of septal thinning and air-space formation (Muglia et al.,
1999), which are similar to those observed in Cited2 and Cebpa
knockouts. However, these histological alterations in cortico-
tropin-releasing hormone-deficient lungs are considered to be
the results of increased alveolar cell proliferation and delayed
epithelial cell maturation while there was no obvious difference
in the alveolar cell proliferation between wild-type and Cited2-
null lungs. In addition, SP-A, -B, -C, and -D mRNA levels were
all significantly down-regulated in E17.5 (data not shown) and
E18.5 (Fig. 3a) Cited2-null lungs, but only SP-A and SP-B
mRNA levels were significantly decreased in E17.5 cortico-
tropin-releasing hormone-deficient lungs. These suggest that
fetal glucocorticoid insufficiency alone cannot explain all the
phenotypes of the pulmonary immaturity in Cited2-null mice.Whether glucocorticoid insufficiency plays a role in Cited2-null
lung phenotype can be directly answered by the analysis of
tissue-specific Cited2 knockout mice.
Cited2 is a negative regulator for HIF-1 in vitro and in vivo
and in its absence VEGF, a target of HIF-1, is overexpressed in
the embryonic heart leading to abnormal coronary vasculature
with higher permeability (Bhattacharya et al., 1999; Xu et al.,
2007). In the lung, overexpression of VEGF under the control of
the SP-C promoter in a transgenic mouse model induces gross
abnormalities in lung morphogenesis and an increase in
peritubular vascularity, with a concomitant decrease in both
epithelial acinar tubules and mesenchyme (Zeng et al., 1998). In
this study, there was no obvious difference in VEGF and
VEGFR2 mRNA levels between wild-type and Cited2-null
lungs at E17.5 (data not shown) and E18 (Fig. 5a). CD31
immunostaining revealed that most pulmonary capillaries
closely abutted alveolar spaces in both wild-type and Cited2-
null lungs at E18.5 (data not shown). Only a few capillaries
embedded in the accumulated cells of E18.5 Cited2-null lungs
were observed. These data suggest that the function of Cited2 as
a negative regulator for HIF-1 may not be responsible for the
pulmonary immaturity in Cited2-null fetal lungs, which is
consistent with our previous finding that HIF-1α heterozygosity
did not rescue lung defects in Cited2-null embryos (Xu et al.,
2007).
Normal lung development is dependent upon reciprocal
interactions between epithelial cells and mesenchymal cells
during embryonic growth and differentiation, which are mediated
by growth and differentiation factors including members of the
fibroblast growth factor (FGF) family, Shh, and members of the
TGF-β family (Warburton et al., 2003; Mendelson, 2000).
Through the coordination with FGF9, FGF10 plays crucial roles
in lung branching morphogenesis during early embryonic lung
development (Min et al., 1998; Sekine et al., 1999; Colvin et al.,
2001). The E18.5 FGF18-null lung is immature, exhibiting
reduced alveolar space, thicker interstitial mesenchymal com-
partments, and embedded capillaries (Usui et al., 2004), which
are prominent features of Cebpa and Cited2 knockout lungs.
Cited2 can be induced by hypoxia, cytokines, lipopolysacchar-
ide, and shear stress (Bhattacharya et al., 1999; Sun et al., 1998;
Yokota et al., 2003). Recently, Haase et al. (2007) showed that
Cited2 promoter activity and mRNA and protein expression can
be induced by basic FGF in NCI-H295R cells. We therefore
propose that upon binding of mesenchyme-expressed FGF18,
FGF receptors of the respiratory epithelial cells undergo
dimerization and auto-phosphorylation (Szebenyi and Fallon,
1999), leading to activation of Cited2 and Cebpa pathways and
subsequent pulmonary maturation. This possibility could be
directly addressed by analyzing Cited2 and Cebpa signaling
pathways in FGF18-null lungs.
TGF-β plays important roles in lung epithelial cell
proliferation and differentiation. Increased expression of TGF-
β inhibited lung maturation in late gestation (Zhou et al., 1996;
Bartram and Speer, 2004) and the expression of surfactant
proteins (Whitsett et al., 1992; Jaskoll et al., 1996). Deletion of
Cebpa enhanced expression of TGF-β2 and Smad3, a major
transcription factor in the TGF-β signaling, in the respiratory
104 B. Xu et al. / Developmental Biology 317 (2008) 95–105epithelium (Martis et al., 2006), suggesting that the effects of
Cebpa deletion may be mediated in part by the activation of
TGF-β2 signaling. Expression of TGF-β2 was also increased in
Cited2-null lungs, likely through the down-regulated expression
of Cebpa in the absence of Cited2 (Fig. 5a). On the other hand,
loss of Cited2 may attenuate TGF-β, since Cited2 has been
shown to be a transcriptional coactivator for Smad2 and Smad3
to enhance TGF-β-mediated transcription (Chou et al., 2006).
Whether increased expression of TGF-β2 or loss of coactivation
function of Cited2 for Smad2/Smad3 plays any role in
pulmonary immaturity in Cited2-null fetal lungs requires further
investigation.
In conclusion, the present study establishes a new role for
Cited2 in lung maturation by modulating gene expression of
Cebpa, which is one of the key transcription factors for
regulating surfactant and Abca3 transcription. Deficiency of
surfactant lipids and proteins in the lung is associated with
respiratory distress syndrome in preterm infants, which is a
common cause of neonatal mortality and morbidity and is
associated with environmental risks and mutations in SP-A, SP-
B, SP-C, and Abca3 (Ramet et al., 2000; Whitsett et al., 2004;
Shulenin et al., 2004). Thus, the knockout mice of the
transcription factors and coactivators, including Cited2, which
are critical for surfactant and Abca3 transcription, are useful
models with which to investigate the etiology and potential
therapeutic strategies to reverse or prevent respiratory distress
syndrome in humans.
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